NCT00068003 2026-04-14Harvesting Cells for Experimental Cancer TreatmentsNational Institutes of Health Clinical Center (CC)Enrolling by invitation7,000 enrolled
NCT07218003 2026-03-23A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Rondo TherapeuticsPhase 1 Enrolling by invitation149 enrolled
NCT07046832 2025-07-02Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue BiopsyMediView XR, Inc.Phase NA Enrolling by invitation104 enrolled